Anna Sundlöv - Concepedia

Author

Anna Sundlöv

Lund University ORCID

Also Known As

A Sundlov, A. Sundlov, A. Sundlöv, Ana Sundlov, Anna Sundlov, Anna Sundlöv, Sundlöv, Anna

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Lund University Skåne University Hospital Sahlgrenska University Hospital University of Gothenburg Oslo University Hospital

About

Anna Sundlöv is an author at Lund University specializing in medicine, neuroendocrine tumors, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	42
2	Medicine	1	1	42
3	Gastroenterology	1	1	42
4	Surgical Oncology	1	1	42
5	Endocrine Surgery	1	1	42

Anna Sundlöv

Publications

916

Citations

H-Index

Page 1

	Year	Citations
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry Anna Sundlöv, Katarina Sjögreen Gleisner, Johanna Svensson, European Journal of Nuclear Medicine and Molecular Imaging	2017	194
Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy Anna Sundlöv, Johan Gustafsson, Gustav Brolin, EJNMMI Physics	2018	95
Bone Marrow Absorbed Doses and Correlations with Hematologic Response During <sup>177</sup>Lu-DOTATATE Treatments Are Influenced by Image-Based Dosimetry Method and Presence of Skeletal Metastases Linn Hagmarker, Johanna Svensson, Tobias Rydèn, Journal of Nuclear Medicine	2019	84
Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with<sup>177</sup>Lu-DOTATATE Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Journal of Nuclear Medicine	2021	78
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients Anna Sundlöv, Katarina Sjögreen Gleisner, Jan Tennvall, European Journal of Nuclear Medicine and Molecular Imaging	2022	71
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy Johan Gustafsson, Anna Sundlöv, Katarina Sjögreen Gleisner EJNMMI Research	2017	43
Long-Term Retention of <sup>177</sup>Lu/<sup>177m</sup>Lu-DOTATATE in Patients Investigated by γ-Spectrometry and γ-Camera Imaging Katarina Sjögreen Gleisner, Gustav Brolin, Anna Sundlöv, Journal of Nuclear Medicine	2015	42
Surgery of the primary tumour in 201 patients with high‐grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine‐non‐neuroendocrine neoplasms Hans‐Christian Pommergaard, Kirstine Nielsen, Halfdan Sørbye, Journal of Neuroendocrinology Surgical OncologyMedian Pfs/dfsCancer ManagementGastroenterologyMedian Dfs	2021	42
A Prospective Observational Study to Evaluate the Effects of Long-Acting Somatostatin Analogs on<sup>68</sup>Ga-DOTATATE Uptake in Patients with Neuroendocrine Tumors Anni Gålne, Helén Almquist, Martin Almquist, Journal of Nuclear Medicine	2019	34
Relationships between uptake of [68Ga]Ga-DOTA-TATE and absorbed dose in [177Lu]Lu-DOTA-TATE therapy Anna Stenvall, Johan Gustafsson, Erik Larsson, EJNMMI Research	2022	29

Page 1